Workflow
Non-GAAP operating expense
icon
Search documents
Phathom Pharmaceuticals(PHAT) - 2025 Q2 - Earnings Call Presentation
2025-08-07 12:00
Business Update Steven Basta, President & Chief Executive Officer Q2 2025 Financial Results Robert Breedlove, VP of Finance & Principal Accounting Officer Closing Remarks SECOND QUARTER 2025 EARNINGS CONFERENCE CALL AUGUST 2025 NASDAQ: PHAT Today's Agenda Steven Basta, President & Chief Executive Officer Question & Answer Steven Basta, President & Chief Executive Officer Robert Breedlove, VP of Finance & Principal Accounting Officer 2 Safe harbor This presentation contains forward-looking statements. All st ...